A new study has revealed that giving patients access to e-services has myriad benefits
Concerns about prescribing practices, costs, and lack of evidence are giving companies pause
After rising by 840% over 16 years, use of the program is expected to accelerate
The new therapy, which replaces an old immediate-release formulation,can cost up to $321,000
Lorne Marr identifies final expense market as an area regulators could make improvements
Inappropriate charges to the province's OHIP program are reportedly in the millions
Those left behind in cases of suicide may get a payout, depending on the type of insurance and certain clauses
The TTC has pinned blame on the insurer for multi-million dollar benefits scam, but how is insurance industry responding?